Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cell/Gene Tx channel feed
Early snapshot of Adverum's eye gene therapy sparks concern about vision loss
6 years ago
R&D
Italian gene therapy player draws new investor from China for its answer to CAR-T relapses
6 years ago
Financing
A new player jumps into the heated race for a sickle cell cure, with help from Google's GV
6 years ago
R&D
London's 4BIO Capital unveils first close of $150M fund dedicated to advanced therapies
6 years ago
Financing
Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B
6 years ago
Financing
Nkarta maps out clinical, manufacturing plans for CAR-NK following $114M round led by Samsara
6 years ago
Financing
Startups
Syncona dives deep into dry AMD R&D, upping Gyroscope bet to $100M
6 years ago
Financing
R&D
Immatics scores $75M upfront in TCR deal with Celgene as interest in tech burgeons
6 years ago
Deals
Adaptimmune pledges $312M for Noile-Immune's T cell boosting tech in drive to deliver on TCR promise
6 years ago
Deals
Cadre of gene-editing biotechs rally against altering DNA that could affect future generations
6 years ago
Biotech targeting rare heart mutation with gene therapy scores $11M in Series A haul
6 years ago
Financing
Startups
Plugging in the last piece to its gene therapy puzzle, AskBio acquires Scottish synthetic promoter company
6 years ago
Deals
Questions pile up for Novartis as senators call on FDA to take action
6 years ago
FDA+
Bayer is going all in on next-gen stem cell biotech BlueRock, buying out Versant and founders for $600M
6 years ago
Deals
Part procedure, part drug: Robert Ang joins Siddhartha Mukherjee in pioneering a new type of cell engineering
6 years ago
People
Startups
Joining Chang and Belldegrun, Rafael Amado takes a leading R&D post in the next big cell therapy revolution
6 years ago
People
PACT Pharma says it's perfected the tech to select neoantigens for personalized therapy — now onto the clinic
6 years ago
Discovery
Keen to stay out front in cell therapy, Gilead's Kite builds its own viral vector manufacturing operations
6 years ago
Takeda's translational cell therapy group revs up for a race to the clinic with off-the-shelf CAR-T
6 years ago
People
Microcap Capricor soars on interim PhII DMD data showing functional benefit for older patients
6 years ago
R&D
Supercharging CAR-T with cancer vaccine, MIT team spotlights some new tech underpinning Darrell Irvine's startup
6 years ago
Discovery
Fresh out of Eli Lilly, Christi Shaw surfaces as Daniel O'Day's new CEO at CAR-T pioneer Kite
6 years ago
People
Billions on the line: BioMarin bustles past enthused rival, planning to launch world’s first hemophilia A gene therapy
6 years ago
The chief scientist at German/US biotech hybrid Immatics is moving to the helm. Here's his to-do list
6 years ago
People
R&D
First page
Previous page
50
51
52
53
54
55
56
Next page
Last page